Search

everythinglearnresearchcommunity

for

Search:↓

Diphencyprone helped most patients with alopecia areata regrow some hair.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

People with alopecia areata have a higher risk of stroke.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

Topical DPCP is somewhat effective for hair loss in alopecia areata, but more research is needed.

Severe pediatric alopecia areata worsens quality of life for patients and families.

The document concludes that more research is needed to understand and treat Beard Alopecia Areata due to limited current knowledge and evidence.

Laser and light therapies, especially the 308 nm excimer laser, are effective and safe for treating alopecia areata, but more research is needed.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

Alopecia areata has a complex genetic basis that was not fully understood as of 2001.

The erbium-glass laser effectively promotes hair regrowth in alopecia areata.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

Hair thickness decreases from the upper to lower areas of the back of the head, affecting hair transplant results.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

Secukinumab for psoriasis may cause hair loss.

A 5-year-old boy's seasonal hair loss is linked to his allergies.

Trichoscopy helps better understand and manage alopecia areata, improving patient outcomes.

A new mix of anthralin and calcipotriene might help treat severe hair loss.

Early intervention with JAK inhibitors may prevent alopecia areata progression.

The dog with an Alopecia Areata-like condition showed signs of an autoimmune disease and partially regrew hair without treatment, suggesting dogs could be models for human AA research.

Upadacitinib may cause hair loss.

Herbal medicine and acupuncture helped regrow hair and reduce pain in a patient with Alopecia Areata.

A combination of methotrexate injections and CO2 laser treatment led to complete hair regrowth in two patients with hard-to-treat alopecia.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

The document suggests there might be a link between Kawasaki Disease and Alopecia Areata that needs more research.

People with rheumatoid arthritis have a higher risk of developing alopecia areata.

Herbal lotions are effective for severe hair loss, with a 64.8% success rate, but relapse is common and long-term management requires allergen control and possible corticosteroid use.